Otsuka & Lundbeck initiates Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder

Read more

Merz and Teijin Announce Partnership to Bring Xeomin (incobotulinumtoxinA) to Japan

Read more

Sanofi invests €170 million in new vaccine production facility in France

Read more

Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business

Read more

Flexion announces FDA Approval of Zilretta for Osteoarthritis (OA) Knee Pain

Read more

Health Canada accepts Mithra’s marketing authorization application for Tibelia

Read more

MilliporeSigma Opens New Life Science Center in Massachusetts

Read more

BioTime Announces First Patient in U.S. Clinical Trial Treated for Facial Volume Deficit

Read more

Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial

Read more

First Patient Treated With Titan Pharmaceuticals’ Subdermal Implant For Parkinson’s Disease

Read more